Inossia Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$8.83M
- Investors
-
12
Inossia General Information
Description
Developer of a fracture treatment softener designed to treat osteoporotic fractures in the spine. The company's softener can be used with acrylic bone cement to modify its properties, making it less stiff by converting the softened cement into a sponge, enabling clinicians to reduce the number of new fractures.
Contact Information
Website
www.inossia.comCorporate Office
- Kungsgatan 64
- 111 22 Stockholm
- Sweden
Corporate Office
- Kungsgatan 64
- 111 22 Stockholm
- Sweden
Inossia Timeline
Inossia Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC | 21-Oct-2026 | $8.83M | Completed | Generating Revenue | ||
| 8. Later Stage VC | 01-Jan-2024 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 6. Later Stage VC | 21-Jun-2023 | Completed | Generating Revenue | |||
| 5. Grant | 11-Jan-2023 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 04-Mar-2020 | Completed | Generating Revenue | |||
| 3. Grant | 20-Jan-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 01-Jan-2017 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-Jan-2013 | Completed | Generating Revenue |
Inossia Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference | ||||||||
| Preference | ||||||||
| Preference | 18,090 | $68.1 | $68.1 | 1x | $68.1 | 18.69% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Inossia Patents
Inossia Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026212555-A1 | Bone cement formulation | Pending | 03-Apr-2025 | ||
| WO-2026182662-A1 | Bone cement formulation exhibiting antibacterial effect | Pending | 27-Feb-2025 | ||
| US-20260137830-A1 | Pmma based composition for use in discoplasty procedures | Pending | 20-Nov-2024 | ||
| WO-2026087460-A1 | Bone cement comprising a bone cement softener for reducing vertebral fractures | Pending | 21-Oct-2024 | ||
| EP-2983725-A1 | Acrylic cements for bone augmentation | Active | 08-Apr-2013 | A61L24/06 |
Inossia Signals
Inossia Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cradle Growth | Growth/Expansion | Minority | ||
| Angel (individual) | Minority | |||
| ScaleUp Life Science Invest | Angel Group | Minority | ||
| Svanberg & Co Invest | PE/Buyout | Minority | ||
| European Innovation Council | Accelerator/Incubator | Minority |
Inossia FAQs
-
When was Inossia founded?
Inossia was founded in 2013.
-
Where is Inossia headquartered?
Inossia is headquartered in Stockholm, Sweden.
-
What is the size of Inossia?
Inossia has 9 total employees.
-
What industry is Inossia in?
Inossia’s primary industry is Surgical Devices.
-
Is Inossia a private or public company?
Inossia is a Private company.
-
What is Inossia’s current revenue?
The current revenue for Inossia is .
-
How much funding has Inossia raised over time?
Inossia has raised $11.9M.
-
Who are Inossia’s investors?
Cradle Growth, , ScaleUp Life Science Invest, Svanberg & Co Invest, and European Innovation Council are 5 of 12 investors who have invested in Inossia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process